Next-Generation Sequencing (NGS)

Next-generation sequencing, often shortened to NGS, is a powerful laboratory technology that reads the genetic code of many genes at the same time, quickly and accurately. In cancer care it is the engine of precision medicine: by examining the DNA and RNA of a tumour, it reveals the specific changes driving that individual cancer and points to the treatments most likely to work against it. The same technology is used to test for inherited cancer risk and to support molecular tumour boards, where specialists match a patient's genetic profile to targeted therapies and clinical options. Because interpreting these results well requires specialised laboratories and expert teams, comprehensive genomic testing is a feature of advanced centres, and many international patients seek it out to guide a clearer, more personalised treatment plan.